Skip To Main Content
Emma E on Muck Rack

Emma E

As seen in: Nature, Frontiers, MDPI, Publico (Portugal)

Get in touch with Emma

Contact Emma, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Emma E’s Biography

Read Full Bio →

Discover Emma's Baby Names Finder. With more than 1000 Baby Girl Names and Baby Boy Names, classified by Origin or from A to Z, you'll find the perfect fit. Emma, 4 Place Ville Marie Suite 300, Montréal, QC H3B 2E7, (438) 806-7227

Articles

What to measure? Development of a Core Outcome Set to assess remote technologies for cochlear implant users.

|
By Catherine Sucher, David Allen, Emma E, Isabelle Boisvert
| preprints.org
Background/Objectives: Uptake of remote cochlear implant (CI) services is feasible in clinical studies, but implementation into regular clinical practice is limited. Effective implementation requires demonstration of at least equivalent outcomes to in-person care. Use of outcome measures that are relevant, and sensitive to both modes of service facilitates evidence-based provision of CI services.
Open in Who Shared Issue with article?

Transforming Circular Economy Thinking Using the Forest as a Metaphor

|
By David Peck Verified, Emma E, Conny A. Bakker
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared View Duplicates (648) Issue with article?

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity | British Journal of Cancer

|
By Emma E, Danielle A. E, van Schelven, van Wettum
| Nature Verified
Abstract Background Peritoneal metastases (PM) in colorectal cancer (CRC) are associated with therapy resistance and poor survival. Oxaliplatin monotherapy is widely applied in the intraperitoneal treatment of PM, but fails to yield clinical benefit. We aimed to identify the mechanism(s) underlying PM resistance to oxaliplatin and to develop strategies overcoming such resistance. Experimental design We generated a biobank consisting of 35 primary tumour regions and 59 paired PM from 12 patients.
Open in Who Shared Issue with article?
See all 4 licensed articles (5 Total)